Search for: "Actavis Pharma, Inc."
Results 101 - 120
of 127
Sorted by Relevance
|
Sort by Date
9 Feb 2015, 1:15 am
Now, Darren sinks his paws on the appeal decision in Hospira (UK) Ltd v Genentech, Inc [2015] EWCA Civ 57 (6 February 2015). [read post]
11 May 2010, 9:06 pm
Robins, Inc., and American Home Products Corporation, and Schwarz Pharma, Inc. [read post]
26 Jan 2015, 4:03 am
* Pharma and biotech patents: a law unto themselves -- and a litigation conference to match? [read post]
24 Mar 2022, 12:04 pm
Actavis, Inc., 570 U.S. 136 (2013), which held that such payments are unlawful when they are “large and unjustified. [read post]
4 May 2011, 7:52 am
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms Morphine Kadian® Extended Release Capsules Actavis Morphine MS Contin Extended Release Tablets … [read post]
28 Mar 2014, 5:33 pm
Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals,… [read post]
16 Feb 2015, 1:44 am
* "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]
3 May 2015, 10:33 pm
With this note, he provides further food for thought on patent law’s complexity, from Bilski to Teva v Leo Pharma, to the relation between patent law and economics. [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
13 Apr 2015, 12:50 pm
| Oprah Winfrey and OWN YOUR POWER trade mark | EPO December Administrative Council Meeting | Blurred Lines | Again on Actavis v Boehringer | Is the EU Patent Package diminishing the EU’s powers? [read post]
17 Oct 2013, 11:09 am
In Pandora Media, Inc. v. [read post]
2 Feb 2015, 2:20 am
Not only did the Dutch Court disagree with the Courts of England and Wales on the matter of priority entitlement and hence validity , but also this ruling appears to be in contrast to the case last week [for which see Katpost here for the first instance and here and here for the appeal judgment] where Arnold J permitted Actavis to launch a product with a skinny label without requiring further measures such as… [read post]
24 Feb 2011, 1:49 pm
Actavis Totowa, LLC, 2010 WL 3604674, at *3-4 (S.D. [read post]
24 May 2019, 8:38 am
, Inc v Jen, Chi [2019] SGIPOS 3. [read post]
16 Nov 2007, 4:00 am
Justice Michel Bastarache, of the Supreme Court of Canada, criticized that court for the 2004 decisions in the Monsanto Canada Inc. v. [read post]
5 Jul 2008, 11:05 am
: (Spicy IP), Aspen pays £170M for IP rights to Eltroxin, Imuran, Lanoxin and Zyloric: (Afro-IP), Year after settling global patent feud over smallpox vaccine, Barvarian Nordic sues Oxford BioMedica over patents related to same virus: (IP Law360), Australia: Age reports former GSK executive’s victory in court action brought by GSK alleging he started a competing business using GSK’s confidential information: (IPwar’s), Brazil: ANVISA to review Brazilian… [read post]
16 Jun 2019, 11:07 am
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
26 May 2019, 2:13 pm
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
2 Apr 2013, 10:33 am
Actavis (12-416). [read post]
13 Jun 2019, 1:06 pm
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
